1. Home
  2. OPRT vs IVVD Comparison

OPRT vs IVVD Comparison

Compare OPRT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRT
  • IVVD
  • Stock Information
  • Founded
  • OPRT 2005
  • IVVD 2020
  • Country
  • OPRT United States
  • IVVD United States
  • Employees
  • OPRT N/A
  • IVVD N/A
  • Industry
  • OPRT Finance: Consumer Services
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPRT Finance
  • IVVD Health Care
  • Exchange
  • OPRT Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • OPRT 110.7M
  • IVVD 116.8M
  • IPO Year
  • OPRT 2019
  • IVVD 2021
  • Fundamental
  • Price
  • OPRT $3.10
  • IVVD $0.76
  • Analyst Decision
  • OPRT Buy
  • IVVD Strong Buy
  • Analyst Count
  • OPRT 4
  • IVVD 5
  • Target Price
  • OPRT $5.17
  • IVVD $9.40
  • AVG Volume (30 Days)
  • OPRT 142.8K
  • IVVD 476.2K
  • Earning Date
  • OPRT 11-12-2024
  • IVVD 11-14-2024
  • Dividend Yield
  • OPRT N/A
  • IVVD N/A
  • EPS Growth
  • OPRT N/A
  • IVVD N/A
  • EPS
  • OPRT N/A
  • IVVD N/A
  • Revenue
  • OPRT $796,905,000.00
  • IVVD $11,564,000.00
  • Revenue This Year
  • OPRT N/A
  • IVVD N/A
  • Revenue Next Year
  • OPRT $5.58
  • IVVD $72.22
  • P/E Ratio
  • OPRT N/A
  • IVVD N/A
  • Revenue Growth
  • OPRT N/A
  • IVVD N/A
  • 52 Week Low
  • OPRT $2.05
  • IVVD $0.76
  • 52 Week High
  • OPRT $4.60
  • IVVD $5.20
  • Technical
  • Relative Strength Index (RSI)
  • OPRT 61.04
  • IVVD 35.46
  • Support Level
  • OPRT $2.82
  • IVVD $0.92
  • Resistance Level
  • OPRT $3.32
  • IVVD $1.02
  • Average True Range (ATR)
  • OPRT 0.22
  • IVVD 0.07
  • MACD
  • OPRT 0.04
  • IVVD -0.02
  • Stochastic Oscillator
  • OPRT 72.97
  • IVVD 0.00

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: